ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Chromocell Therapeutics Corporation

Chromocell Therapeutics Corporation (CHRO)

1.54
0.315
(25.71%)
Closed April 21 4:00PM
1.54
0.00
(0.00%)
After Hours: 7:35PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.54
Bid
-
Ask
-
Volume
119,290
1.30 Day's Range 1.75
1.21 52 Week Range 6.00
Market Cap
Previous Close
1.225
Open
1.30
Last Trade
100
@
1.54
Last Trade Time
Financial Volume
$ 179,841
VWAP
1.5076
Average Volume (3m)
30,164
Shares Outstanding
5,767,525
Dividend Yield
-
PE Ratio
-3.61
Earnings Per Share (EPS)
-0.43
Revenue
-
Net Profit
-2.46M

About Chromocell Therapeutics Corporation

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Chromocell Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Chromocell Therapeutics was $1.23. Over the last year, Chromocell Therapeutics shares have traded in a share price range of $ 1.21 to $ 6.00.

Chromocell Therapeutics currently has 5,767,525 shares outstanding. The market capitalization of Chromocell Therapeutics is $8.88 million. Chromocell Therapeutics has a price to earnings ratio (PE ratio) of -3.61.

CHRO Latest News

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...

Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions

AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. (“Chromocell”), (NYSE American:...

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

FREEHOLD, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell”, “our”, “us” or the “Company”), a clinical-stage biotech company focused...

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

FREEHOLD, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell” or the “Company”), a clinical-stage biotech company focused on...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.32-17.20430107531.862.24991.21208921.74446714CS
4-1.28-45.3900709222.822.821.21310662.35022097CS
12-4.46-74.3333333333661.21301643.22635508CS
26-4.46-74.3333333333661.21301643.22635508CS
52-4.46-74.3333333333661.21301643.22635508CS
156-4.46-74.3333333333661.21301643.22635508CS
260-4.46-74.3333333333661.21301643.22635508CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

Discussion

View Full Feed
Italia77 Italia77 4 minutes ago
200k volume on Friday, let's see a PR here $HGYN!
HGYN
Hummingbird2 Hummingbird2 14 minutes ago
https://www.youtube.com/watch?v=NdPHHYJHVlQ
GTII
bslate243 bslate243 14 minutes ago
I have, all the info they have is her name and some weird black and white photo of her.

That being said, you can tell she wants this company to succeed and is putting some bold expectations on the X account including cancelling 300m shares. If I’m not mistaken, that’s nearly 1/4 of t
NGCG
wagner wagner 14 minutes ago
Would you make a bet on this?......
NB
Ranb2khz Ranb2khz 21 minutes ago
Likewise my friend - I am also looking forward to the rapture! I am also happy that the Lord has tarried this long though, as it gives more time for the lost souls to repent. As the Lord points out in 2 Peter 3:9 - “He does not wish for any to perish, but for all to come to repentance”.
louieforpar louieforpar 36 minutes ago
Seems Trump didn’t want his hair to get wet. Whatever happened to his “big indoor” venues?

Either he can’t afford it due to his money issues or his crowd sizes don’t warrant it.






https://www.wect.com/2024/04/18/wect-livestream-tru
DJT
thistraderknowsall thistraderknowsall 42 minutes ago
SHIB Altcoin upgrade !!!!! SHIB worth .01 now!! Congrats!

Shibarium, the layer-2 (L2) blockchain of the Shiba Inu [SHIB] ecosystem, announced a major UI upgrade. It’s aimed at improving user experience and broadening options for network interactions.

According to Shibar
TRAPPER JIM TRAPPER JIM 42 minutes ago
Sleeping in my chair with Oreo tonight. He’s sick and just not feeling well at all. He’s been throwing up and just like standing around like he doesn’t know what’s going on . Just staring out into space.
peterus peterus 43 minutes ago
geez man insiders own 4.5%
tell it all .... dilution pos
JAGX
joev2 joev2 44 minutes ago
TA, I see we both read each others boards. My intro to Sint (couldn't even remember at first) was when I saw it crashed sometime in 2016. Somehow, it caught my attention via headline or maybe biggest loser of day. Curious about it, I proceeded cautiously, thinking it was possible (exceptionally rare
SINT
newmedman newmedman 47 minutes ago
that thread is friggin hilarious. LOL poor old poopy pants.
money-maker money-maker 48 minutes ago
https://twitter.com/TropicsStephen/status/1781600574049583544?t=B5whDwNll-2R5O5vvh4cbw&s=19
SPZI
Pastortec Pastortec 52 minutes ago
BAYER i recommend buy VOIS. The company that sell the stocks sell with them all its patents and one of them can influence with certain on your future sales.
VOIS
shermann7 shermann7 1 hour ago
I personally think that Tulsi Gabbard is the Leading candidate to be Trumps VP candidate ... For whatever that is worth ...

Shermann
S-Boogie S-Boogie 1 hour ago
"Delinquent SEC Reporting"... I guess nate has officially washed his hands of this ticker.
NHMD
Horseb4CarT Horseb4CarT 1 hour ago
I used to drink one glass of red wine with dinner and had replaced that with nonalcoholic low calorie beer. Then my last lab results were shockingly different (bad) and I’m drinking water, coffee, and green and herbal teas and as little sugar as possible and very low carbs in general.
NWBO
kgromax kgromax 1 hour ago
Excepted it shows Cytodyn was nowhere and has lied to its investors. What about that BLA data claimed publicly (PR!) by the CEO Nader to have been submitted to the FDA but that in fact was NOT submitted?

A corporate scam.
CYDY
Preciouslife1 Preciouslife1 1 hour ago
https://www.facebook.com/share/r/VMyMPw4dsAAMef7V/?mibextid=6GsUZ4
janice shell janice shell 2 hours ago
This is SO SAD!!

https://twitter.com/CalltoActivism/status/1781758041609646286
janice shell janice shell 2 hours ago
This is SO SAD!!

https://twitter.com/CalltoActivism/status/1781758041609646286
satter satter 2 hours ago
I don't hold Trump for words taken out of context, or when it's a snippet and it's missing the complete video. If I do then point it out. You want to argue he did not say Bleach. I won't argue and say he said it. There is plenty to argue on what he did say. And that is a perfect example of you peopl
DJT
Investor2014 Investor2014 2 hours ago
That is correct.
I would suspect that many of the 1.7 million pages will never see the light of day
The vast majority of 'pages' of a regulatory submission consist of data items that may be part of various assessments done in the approval process, but unlikely that all is covered and u
AVXL
Wise Man Wise Man 2 hours ago
The link between unrealized losses and the conservatorship is clear.
FnF were placed in conservatorship pursuant to the FHEFSSA section 1367(a) APPOINTMENT OF THE AGENCY AS CONSERVATOR (which, by the way, was an amendment inserted by HERA in the FHEFSSA), according to the SPSPA:
https:
FNMA

Your Recent History

Delayed Upgrade Clock